Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy.

Reddy SK, Parker RJ, Leach JW, Hill MJ, Burgart LJ.

J Surg Oncol. 2016 Mar;113(4):456-62. doi: 10.1002/jso.24144. Epub 2016 Jan 12.

PMID:
27100028
2.

Imaging Surveillance of Hypervascular Liver Lesions in Non-Cirrhotic Patients.

Chun YS, Parker RJ, Inampudi S, Ehrenwald E, Batts KP, Burgart LJ, Schumacher CW, Mehling JA, Engstrom BI, Hill MJ, Reddy SK, Sielaff TD.

J Gastrointest Surg. 2016 Mar;20(3):564-7. doi: 10.1007/s11605-015-2942-9. Epub 2015 Sep 16.

PMID:
26376993
3.

CT colonography for the detection of nonpolypoid adenomas: sensitivity assessed with restricted national CT colonography trial criteria.

Fidler JL, Zhang Z, Herman BA, Limburg PJ, Fletcher JG, Dachman A, Heiken JP, Kuo MD, Menias CO, Siewert B, Cheema JI, Obregon RG, Zimmerman P, Horton KM, Coakley K, Iyer RB, Hara A, Halvorsen RA Jr, Casola G, Yee J, Burgart LJ, Johnson CD.

AJR Am J Roentgenol. 2014 Dec;203(6):W614-22. doi: 10.2214/AJR.13.12356.

4.

The National CT Colonography Trial: assessment of accuracy in participants 65 years of age and older.

Johnson CD, Herman BA, Chen MH, Toledano AY, Heiken JP, Dachman AH, Kuo MD, Menias CO, Siewert B, Cheema JI, Obregon R, Fidler JL, Zimmerman P, Horton KM, Coakley KJ, Iyer RB, Hara AK, Halvorsen RA Jr, Casola G, Yee J, Blevins M, Burgart LJ, Limburg PJ, Gatsonis CA.

Radiology. 2012 May;263(2):401-8. doi: 10.1148/radiol.12102177. Epub 2012 Feb 23.

5.

Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases.

Glasgow SC, Bleier JI, Burgart LJ, Finne CO, Lowry AC.

J Gastrointest Surg. 2012 May;16(5):1019-28. doi: 10.1007/s11605-012-1827-4. Epub 2012 Jan 19. Review.

PMID:
22258880
6.

Protocol for the examination of specimens from patients with carcinoma of the distal extrahepatic bile ducts.

Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Apr;134(4):e8-13. doi: 10.1043/1543-2165-134.4.e8. No abstract available.

PMID:
20367298
7.

Protocol for the examination of specimens from patients with carcinoma of the perihilar bile ducts.

Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Apr;134(4):e19-24. doi: 10.1043/1543-2165-134.4.e19. No abstract available.

PMID:
20367295
8.

Protocol for the examination of specimens from patients with carcinoma of the intrahepatic bile ducts.

Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Apr;134(4):e14-8. doi: 10.1043/1543-2165-134.4.e14. No abstract available.

PMID:
20367294
9.

AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, Lewis JD, Ullman TA, James T 3rd, McLeod R, Burgart LJ, Allen J, Brill JV; AGA Institute Medical Position Panel on Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease.

Gastroenterology. 2010 Feb;138(2):738-45. doi: 10.1053/j.gastro.2009.12.037. No abstract available.

PMID:
20141808
10.

Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the stomach.

Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Feb;134(2):187-91. doi: 10.1043/1543-2165-134.2.187. No abstract available.

PMID:
20121605
11.

Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the small intestine and ampulla.

Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Feb;134(2):181-6. doi: 10.1043/1543-2165-134.2.181. No abstract available.

PMID:
20121604
12.

Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the colon and rectum.

Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Feb;134(2):176-80. doi: 10.1043/1543-2165-134.2.176. No abstract available.

PMID:
20121603
13.

Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the appendix.

Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Feb;134(2):171-5. doi: 10.1043/1543-2165-134.2.171. No abstract available.

PMID:
20121602
14.

Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum.

Washington MK, Berlin J, Branton P, Burgart LJ, Carter DK, Fitzgibbons PL, Halling K, Frankel W, Jessup J, Kakar S, Minsky B, Nakhleh R, Compton CC; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2009 Oct;133(10):1539-51. doi: 10.1043/1543-2165-133.10.1539. No abstract available.

15.

Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.

Kakar S, Chen X, Ho C, Burgart LJ, Adeyi O, Jain D, Sahai V, Ferrell LD.

Histopathology. 2009 Aug;55(2):197-205. doi: 10.1111/j.1365-2559.2009.03343.x.

16.

Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization.

Kakar S, Chen X, Ho C, Burgart LJ, Sahai V, Dachrut S, Yabes A, Jain D, Ferrell LD.

Mod Pathol. 2009 Jan;22(1):134-41. doi: 10.1038/modpathol.2008.178. Epub 2008 Nov 7.

17.

Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL.

Ann Intern Med. 2008 Oct 7;149(7):441-50, W81.

18.

Accuracy of CT colonography for detection of large adenomas and cancers.

Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, Kuo MD, Menias CO, Siewert B, Cheema JI, Obregon RG, Fidler JL, Zimmerman P, Horton KM, Coakley K, Iyer RB, Hara AK, Halvorsen RA Jr, Casola G, Yee J, Herman BA, Burgart LJ, Limburg PJ.

N Engl J Med. 2008 Sep 18;359(12):1207-17. doi: 10.1056/NEJMoa0800996. Erratum in: N Engl J Med. 2008 Dec 25;359(26):2853.

19.

Altered DNA mismatch repair expression in synchronous and metachronous colorectal cancers.

Aslanian HR, Burgart LJ, Harrington JJ, Mahoney DW, Zinsmeister AR, Thibodeau SN, Ahlquist DA.

Clin Gastroenterol Hepatol. 2008 Dec;6(12):1385-8. doi: 10.1016/j.cgh.2008.04.027. Epub 2008 Jul 17.

PMID:
18639494
20.

The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.

Aderca I, Moser CD, Veerasamy M, Bani-Hani AH, Bonilla-Guerrero R, Ahmed K, Shire A, Cazanave SC, Montoya DP, Mettler TA, Burgart LJ, Nagorney DM, Thibodeau SN, Cunningham JM, Lai JP, Roberts LR.

J Hepatol. 2008 Sep;49(3):373-83. doi: 10.1016/j.jhep.2008.05.015. Epub 2008 Jun 9.

21.

Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum.

Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Compton CC; Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2008 Jul;132(7):1182-93. doi: 10.1043/1543-2165(2008)132[1182:PFTEOS]2.0.CO;2. No abstract available. Erratum in: Arch Pathol Lab Med. 2008 Sep;132(9):1384.

PMID:
18605770
22.

Predictors of family risk for celiac disease: a population-based study.

Rubio-Tapia A, Van Dyke CT, Lahr BD, Zinsmeister AR, El-Youssef M, Moore SB, Bowman M, Burgart LJ, Melton LJ 3rd, Murray JA.

Clin Gastroenterol Hepatol. 2008 Sep;6(9):983-7. doi: 10.1016/j.cgh.2008.04.008. Epub 2008 Jun 30.

23.

Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.

French AJ, Sargent DJ, Burgart LJ, Foster NR, Kabat BF, Goldberg R, Shepherd L, Windschitl HE, Thibodeau SN.

Clin Cancer Res. 2008 Jun 1;14(11):3408-15. doi: 10.1158/1078-0432.CCR-07-1489.

24.

Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma.

Buckley AF, Burgart LJ, Sahai V, Kakar S.

Am J Clin Pathol. 2008 Feb;129(2):245-51. doi: 10.1309/WF10QAAED3PP93BH.

PMID:
18208805
25.

Frequency of defective DNA mismatch repair in colorectal cancer among the Alaska Native people.

Boardman LA, Lanier AP, French AJ, Schowalter KV, Burgart LJ, Koller KR, McDonnell SK, Schaid DJ, Thibodeau SN.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2344-50.

26.

Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.

Jenkins MA, Hayashi S, O'Shea AM, Burgart LJ, Smyrk TC, Shimizu D, Waring PM, Ruszkiewicz AR, Pollett AF, Redston M, Barker MA, Baron JA, Casey GR, Dowty JG, Giles GG, Limburg P, Newcomb P, Young JP, Walsh MD, Thibodeau SN, Lindor NM, Lemarchand L, Gallinger S, Haile RW, Potter JD, Hopper JL, Jass JR; Colon Cancer Family Registry.

Gastroenterology. 2007 Jul;133(1):48-56. Epub 2007 Apr 25.

27.

Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability.

Sinicrope FA, Rego RL, Garrity-Park MM, Foster NR, Sargent DJ, Goldberg RM, Wiesenfeld M, Witzig TE, Thibodeau SN, Burgart LJ.

Int J Cancer. 2007 Mar 15;120(6):1232-8.

28.

Atrophic autoimmune pangastritis: A distinctive form of antral and fundic gastritis associated with systemic autoimmune disease.

Jevremovic D, Torbenson M, Murray JA, Burgart LJ, Abraham SC.

Am J Surg Pathol. 2006 Nov;30(11):1412-9.

PMID:
17063082
29.

Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers.

Sinicrope FA, Rego RL, Foster N, Sargent DJ, Windschitl HE, Burgart LJ, Witzig TE, Thibodeau SN.

Am J Gastroenterol. 2006 Dec;101(12):2818-25. Epub 2006 Oct 6.

PMID:
17026563
30.

MR elastography of the liver: preliminary results.

Rouvière O, Yin M, Dresner MA, Rossman PJ, Burgart LJ, Fidler JL, Ehman RL.

Radiology. 2006 Aug;240(2):440-8.

PMID:
16864671
31.

An internally covered (lined) self-expanding metal esophageal stent: tissue response in a porcine model.

Baron TH, Burgart LJ, Pochron NL.

Gastrointest Endosc. 2006 Aug;64(2):263-7.

PMID:
16860080
32.

Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid.

Sanchez W, Maple JT, Burgart LJ, Kamath PS.

Mayo Clin Proc. 2006 Apr;81(4):541-4.

PMID:
16610575
33.
34.

Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia.

Osborn NK, Zou H, Molina JR, Lesche R, Lewin J, Lofton-Day C, Klatt KK, Harrington JJ, Burgart LJ, Ahlquist DA.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):212-8.

PMID:
16469682
35.

Frozen section analysis of esophageal endoscopic mucosal resection specimens in the real-time management of Barrett's esophagus.

Prasad GA, Wang KK, Lutzke LS, Lewis JT, Sanderson SO, Buttar NS, Wong Kee Song LM, Borkenhagen LS, Burgart LJ.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):173-8.

36.

Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features.

Mahmud FH, Murray JA, Kudva YC, Zinsmeister AR, Dierkhising RA, Lahr BD, Dyck PJ, Kyle RA, El-Youssef M, Burgart LJ, Van Dyke CT, Brogan DL, Melton LJ 3rd.

Mayo Clin Proc. 2005 Nov;80(11):1429-34.

37.

A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.

Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, Dahl TR, Foster N, Sargent DJ; Pancreas Cancer Working Group.

Surgery. 2005 Oct;138(4):618-28; discussion 628-30.

PMID:
16269290
38.

Testing for defective DNA mismatch repair in colorectal carcinoma: a practical guide.

Burgart LJ.

Arch Pathol Lab Med. 2005 Nov;129(11):1385-9. Review.

PMID:
16253016
39.

Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in mice.

Wuestefeld T, Klein C, Streetz KL, Beraza N, Schölmerich J, Burgart LJ, Zender L, Kubicka S, Baskin-Bey E, Gores GJ, Manns MP, Trautwein C.

Hepatology. 2005 Nov;42(5):1082-90. Erratum in: Hepatology. 2005 Dec;42(6):1471. Baskin-Bey, Edwina [added].

PMID:
16250046
40.

Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.

Gawrieh S, Papouchado BG, Burgart LJ, Kobayashi S, Charlton MR, Gores GJ.

Liver Transpl. 2005 Oct;11(10):1207-13.

41.

Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.

Gill S, Lindor NM, Burgart LJ, Smalley R, Leontovich O, French AJ, Goldberg RM, Sargent DJ, Jass JR, Hopper JL, Jenkins MA, Young J, Barker MA, Walsh MD, Ruszkiewicz AR, Thibodeau SN.

Clin Cancer Res. 2005 Sep 15;11(18):6466-71.

42.

Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome.

Baudhuin LM, Burgart LJ, Leontovich O, Thibodeau SN.

Fam Cancer. 2005;4(3):255-65. Review.

PMID:
16136387
43.

Outcome of untreated grade II rejection on solitary pancreas allograft biopsy specimens.

Casey ET, Smyrk TC, Burgart LJ, Stegall MD, Larson TS.

Transplantation. 2005 Jun 27;79(12):1717-22.

PMID:
15973174
44.
45.

Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.

Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero Y, Burgart LJ, Ahlquist DA.

Int J Cancer. 2005 Sep 10;116(4):584-91.

46.

Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.

Zou H, Osborn NK, Harrington JJ, Klatt KK, Molina JR, Burgart LJ, Ahlquist DA.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):830-4.

47.

Hepatic copper in patients receiving long-term total parenteral nutrition.

Blaszyk H, Wild PJ, Oliveira A, Kelly DG, Burgart LJ.

J Clin Gastroenterol. 2005 Apr;39(4):318-20.

PMID:
15758626
48.

Long-term survival after local excision for T1 carcinoma of the rectum.

Nascimbeni R, Nivatvongs S, Larson DR, Burgart LJ.

Dis Colon Rectum. 2004 Nov;47(11):1773-9. Erratum in: Dis Colon Rectum. 2005 Jun;48(6):1325-6.

PMID:
15622568
49.

Development of a fluorescent multiplex assay for detection of MSI-High tumors.

Bacher JW, Flanagan LA, Smalley RL, Nassif NA, Burgart LJ, Halberg RB, Megid WM, Thibodeau SN.

Dis Markers. 2004;20(4-5):237-50.

50.

Widespread EMR: a new technique for removal of large areas of mucosa.

Rajan E, Gostout CJ, Feitoza AB, Leontovich ON, Herman LJ, Burgart LJ, Chung S, Cotton PB, Hawes RH, Kalloo AN, Kantsevoy SV, Pasricha PJ.

Gastrointest Endosc. 2004 Oct;60(4):623-7.

PMID:
15472695

Supplemental Content

Loading ...
Support Center